" class="no-js "lang="en-US"> David Jenkins Discussing Antimicrobial Chemotherapy
Monday, May 20, 2024

David Jenkins, University Hospitals of Leicester, Discussing Antimicrobial Chemotherapy

In the video, David Jenkins, a consultant medical microbiologist from the University Hospitals of Leicester, discusses the issue of antibiotic resistance and the need for the development of new antibiotics. He also highlights the importance of organisations such as the British Society for Antimicrobial Chemotherapy (BSAC) in tackling this unmet need.

Jenkins also discusses how BSAC provides education to members through meetings and online webinars, as well as publishing leading journals.

Overall, Jenkins stresses the urgent need for action to address the growing problem of antibiotic resistance and calls for a collaborative effort between healthcare professionals, researchers, and policymakers to ensure the continued availability of effective antibiotics for the treatment of infectious diseases across not just the UK, but the world.

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more